Global Amyotrophic Lateral Sclerosis (ALS) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Amyotrophic Lateral Sclerosis (ALS) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Amyotrophic Lateral Sclerosis (ALS) by Country/Region, 2017, 2022 & 2028

2.2 Amyotrophic Lateral Sclerosis (ALS) Segment by Type

2.2.1 Riluzole

2.2.2 Edaravone (Radicava)

2.2.3 Other

2.3 Amyotrophic Lateral Sclerosis (ALS) Sales by Type

2.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2022)

2.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Type (2017-2022)

2.4 Amyotrophic Lateral Sclerosis (ALS) Segment by Application

2.4.1 Hospital

2.4.2 Drugs Store

2.4.3 Other

2.5 Amyotrophic Lateral Sclerosis (ALS) Sales by Application

2.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Sale Market Share by Application (2017-2022)

2.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Application (2017-2022)

3 Global Amyotrophic Lateral Sclerosis (ALS) by Company

3.1 Global Amyotrophic Lateral Sclerosis (ALS) Breakdown Data by Company

3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Annual Sales by Company (2020-2022)

3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Company (2020-2022)

3.2 Global Amyotrophic Lateral Sclerosis (ALS) Annual Revenue by Company (2020-2022)

3.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Company (2020-2022)

3.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Company (2020-2022)

3.3 Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Company

3.4 Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Location Distribution

3.4.2 Players Amyotrophic Lateral Sclerosis (ALS) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Amyotrophic Lateral Sclerosis (ALS) by Geographic Region

4.1 World Historic Amyotrophic Lateral Sclerosis (ALS) Market Size by Geographic Region (2017-2022)

4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Annual Revenue by Geographic Region

4.2 World Historic Amyotrophic Lateral Sclerosis (ALS) Market Size by Country/Region (2017-2022)

4.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Annual Revenue by Country/Region

4.3 Americas Amyotrophic Lateral Sclerosis (ALS) Sales Growth

4.4 APAC Amyotrophic Lateral Sclerosis (ALS) Sales Growth

4.5 Europe Amyotrophic Lateral Sclerosis (ALS) Sales Growth

4.6 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Growth

5 Americas

5.1 Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Country

5.1.1 Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022)

5.1.2 Americas Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022)

5.2 Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Type

5.3 Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Region

6.1.1 APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022)

6.1.2 APAC Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022)

6.2 APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Type

6.3 APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Amyotrophic Lateral Sclerosis (ALS) by Country

7.1.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022)

7.1.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022)

7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type

7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) by Country

8.1.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022)

8.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type

8.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Amyotrophic Lateral Sclerosis (ALS)

10.3 Manufacturing Process Analysis of Amyotrophic Lateral Sclerosis (ALS)

10.4 Industry Chain Structure of Amyotrophic Lateral Sclerosis (ALS)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Amyotrophic Lateral Sclerosis (ALS) Distributors

11.3 Amyotrophic Lateral Sclerosis (ALS) Customer

12 World Forecast Review for Amyotrophic Lateral Sclerosis (ALS) by Geographic Region

12.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Region

12.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Forecast by Region (2023-2028)

12.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Amyotrophic Lateral Sclerosis (ALS) Forecast by Type

12.7 Global Amyotrophic Lateral Sclerosis (ALS) Forecast by Application

13 Key Players Analysis

13.1 Mitsubishi Tanabe Pharma

13.1.1 Mitsubishi Tanabe Pharma Company Information

13.1.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

13.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Mitsubishi Tanabe Pharma Main Business Overview

13.1.5 Mitsubishi Tanabe Pharma Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Amyotrophic Lateral Sclerosis (ALS) Product Offered

13.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 Mylan Pharma

13.3.1 Mylan Pharma Company Information

13.3.2 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

13.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mylan Pharma Main Business Overview

13.3.5 Mylan Pharma Latest Developments

13.4 Apotex

13.4.1 Apotex Company Information

13.4.2 Apotex Amyotrophic Lateral Sclerosis (ALS) Product Offered

13.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Apotex Main Business Overview

13.4.5 Apotex Latest Developments

13.5 Glemark Generics

13.5.1 Glemark Generics Company Information

13.5.2 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product Offered

13.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Glemark Generics Main Business Overview

13.5.5 Glemark Generics Latest Developments

13.6 Covis Pharma

13.6.1 Covis Pharma Company Information

13.6.2 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

13.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Covis Pharma Main Business Overview

13.6.5 Covis Pharma Latest Developments

13.7 Sun Pharma

13.7.1 Sun Pharma Company Information

13.7.2 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

13.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sun Pharma Main Business Overview

13.7.5 Sun Pharma Latest Developments

13.8 Lunan Pharma

13.8.1 Lunan Pharma Company Information

13.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

13.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Lunan Pharma Main Business Overview

13.8.5 Lunan Pharma Latest Developments

14 Research Findings and Conclusion

Table 1. Amyotrophic Lateral Sclerosis (ALS) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Amyotrophic Lateral Sclerosis (ALS) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Riluzole

Table 4. Major Players of Edaravone (Radicava)

Table 5. Major Players of Other

Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2022)

Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & ($ million)

Table 9. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2022)

Table 10. Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Type (2017-2022) & (USD/MT)

Table 11. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 12. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2022)

Table 13. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022)

Table 14. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2022)

Table 15. Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Application (2017-2022) & (USD/MT)

Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Company (2020-2022) & (K MT)

Table 17. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Company (2020-2022)

Table 18. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Company (2020-2022)

Table 20. Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Company (2020-2022) & (USD/MT)

Table 21. Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Producing Area Distribution and Sales Area

Table 22. Players Amyotrophic Lateral Sclerosis (ALS) Products Offered

Table 23. Amyotrophic Lateral Sclerosis (ALS) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share Geographic Region (2017-2022)

Table 28. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country/Region (2017-2022)

Table 32. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)

Table 35. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2022)

Table 36. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2022)

Table 38. Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 39. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2022)

Table 40. Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 41. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2022)

Table 42. APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)

Table 43. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2022)

Table 44. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2017-2022)

Table 46. APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 47. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2022)

Table 48. APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 49. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2022)

Table 50. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)

Table 51. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2022)

Table 52. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2022)

Table 54. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 55. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2022)

Table 56. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 57. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis (ALS)

Table 67. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis (ALS)

Table 68. Key Industry Trends of Amyotrophic Lateral Sclerosis (ALS)

Table 69. Amyotrophic Lateral Sclerosis (ALS) Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Amyotrophic Lateral Sclerosis (ALS) Distributors List

Table 72. Amyotrophic Lateral Sclerosis (ALS) Customer List

Table 73. Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Forecast by Region

Table 75. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share Forecast by Application (2023-2028)

Table 93. Mitsubishi Tanabe Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

Table 94. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

Table 95. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 96. Mitsubishi Tanabe Pharma Main Business

Table 97. Mitsubishi Tanabe Pharma Latest Developments

Table 98. Sanofi Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi Amyotrophic Lateral Sclerosis (ALS) Product Offered

Table 100. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 101. Sanofi Main Business

Table 102. Sanofi Latest Developments

Table 103. Mylan Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

Table 104. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

Table 105. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 106. Mylan Pharma Main Business

Table 107. Mylan Pharma Latest Developments

Table 108. Apotex Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

Table 109. Apotex Amyotrophic Lateral Sclerosis (ALS) Product Offered

Table 110. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 111. Apotex Main Business

Table 112. Apotex Latest Developments

Table 113. Glemark Generics Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

Table 114. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product Offered

Table 115. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 116. Glemark Generics Main Business

Table 117. Glemark Generics Latest Developments

Table 118. Covis Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

Table 119. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

Table 120. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 121. Covis Pharma Main Business

Table 122. Covis Pharma Latest Developments

Table 123. Sun Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

Table 124. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

Table 125. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 126. Sun Pharma Main Business

Table 127. Sun Pharma Latest Developments

Table 128. Lunan Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

Table 129. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offered

Table 130. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 131. Lunan Pharma Main Business

Table 132. Lunan Pharma Latest Developments

List of Figures

Figure 1. Picture of Amyotrophic Lateral Sclerosis (ALS)

Figure 2. Amyotrophic Lateral Sclerosis (ALS) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Riluzole

Figure 10. Product Picture of Edaravone (Radicava)

Figure 11. Product Picture of Other

Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type in 2021

Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2022)

Figure 14. Amyotrophic Lateral Sclerosis (ALS) Consumed in Hospital

Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Market: Hospital (2017-2022) & (K MT)

Figure 16. Amyotrophic Lateral Sclerosis (ALS) Consumed in Drugs Store

Figure 17. Global Amyotrophic Lateral Sclerosis (ALS) Market: Drugs Store (2017-2022) & (K MT)

Figure 18. Amyotrophic Lateral Sclerosis (ALS) Consumed in Other

Figure 19. Global Amyotrophic Lateral Sclerosis (ALS) Market: Other (2017-2022) & (K MT)

Figure 20. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2022)

Figure 21. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application in 2021

Figure 22. Amyotrophic Lateral Sclerosis (ALS) Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Company in 2021

Figure 24. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Geographic Region in 2021

Figure 26. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2022)

Figure 27. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country/Region in 2021

Figure 28. Americas Amyotrophic Lateral Sclerosis (ALS) Sales 2017-2022 (K MT)

Figure 29. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue 2017-2022 ($ Millions)

Figure 30. APAC Amyotrophic Lateral Sclerosis (ALS) Sales 2017-2022 (K MT)

Figure 31. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue 2017-2022 ($ Millions)

Figure 32. Europe Amyotrophic Lateral Sclerosis (ALS) Sales 2017-2022 (K MT)

Figure 33. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales 2017-2022 (K MT)

Figure 35. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue 2017-2022 ($ Millions)

Figure 36. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2021

Figure 37. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country in 2021

Figure 38. United States Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region in 2021

Figure 43. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Regions in 2021

Figure 44. China Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2021

Figure 51. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country in 2021

Figure 52. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country in 2021

Figure 59. Egypt Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Amyotrophic Lateral Sclerosis (ALS) in 2021

Figure 65. Manufacturing Process Analysis of Amyotrophic Lateral Sclerosis (ALS)

Figure 66. Industry Chain Structure of Amyotrophic Lateral Sclerosis (ALS)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles